Living Medical
Textbook
From Projects In Knowledge
 
Osteoporosis
Fracture Prevention and Therapeutic Management Edition
Table of Contents  |  CME/CE Information  | Technical Requirements  | Login 
 
/1892/images/PIKEduInit.gif [NO]/1892/iPhoneAd/1892iPhoneAd.gif [NO]
Chapter 1
Overview of Osteoporosis

Last Reviewed: May 20, 2010
Chapter 2
Identifying Patients at Risk for Osteoporosis and Fractures

Last Reviewed: May 20, 2010
Chapter 3
Assessment of Fracture Risk Using FRAX®

Last Reviewed: May 20, 2010
Assessing Fracture Risk in Clinical Practice
What is FRAX?
Using FRAX in Clinical Practice
Treatment Decisions Using FRAX
Limitations and Caveats
References
 
Chapter 4
Treatment of Osteoporosis

Last Reviewed: May 20, 2010
Chapter 5
Management of the Postfracture Patient

Last Reviewed: May 20, 2010
Chapter 6
Monitoring

Last Reviewed: May 20, 2010


Sponsor
Projects In Knowledge®


Peer Reviewed
This activity is supported by an educational donation provided by Amgen.



Osteoporosis News powered by
MedPage Today
 
This CME program will include a brief pretest. Please start now by answering these 4 questions:

1.Which of the following is not an output of FRAX? *
10-year probability of vertebral fracture
10-year probability of major osteoporotic fracture
10-year probability of hip fracture
All of the above are outputs of FRAX
2.Which of the following risk thresholds calculated by FRAX (in a postmenopausal woman) is an indication for treatment according to the National Osteoporosis Foundation? *
10-year risk of major osteoporotic fracture of 18%
10-year risk of hip fracture of 4%
10-year risk of major osteoporotic fracture of 15%
10-year risk of hip fracture of 2%
3.FRAX may underestimate fracture risk in a woman who: *
Smokes two packs of cigarettes per day.
Has a prevalent clinical vertebral fracture.
Uses inhaled steroids to treat her asthma.
Drinks one glass of wine each night with dinner.
4.How often do you currently use each of the following clinical practice strategies? *
  Always Very Often Sometimes Not Very Often Never N/A
Utilize FRAX® for postmenopausal women or men aged 50 years and over with osteopenia to estimate 10-year fracture risk
Use National Osteoporosis treatment guidelines to make treatment decisions based on FRAX results in postmenopausal women or men aged 50 years and over with osteopenia
Complete the FRAX questionnaire with full understanding of the data requested
Use the FRAX questionnaire and results as a basis for patient education regarding fracture risk reduction by nonpharmacologic therapy or bone-active agents
Use clinical judgment when completing the FRAX questionnaire and interpreting FRAX results
 
 




ABOUT US  |  CONTACT US  |  CONTRACT  |  DIRECTIONS  |  PRIVACY POLICY  |  RESOURCES
Copyright © 1997-2010, Projects In Knowledge, Inc. All rights reserved.
PROJECTS IN KNOWLEDGE • Overlook at Great Notch • 150 Clove Road, 10th Floor • Little Falls, New Jersey 07424 (973) 890-8988